Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Howard

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|November 19, 2015
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd editionHellen Gelband, Rengaswamy Sankaranarayanan, Cindy L Gauvreau, et al.
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
British Journal of Haematology|April 3, 2015
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group studyTerzah M Horton, Richard A Drachtman, Lu Chen, et al.
Cancers|January 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European RegistryBertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Cancers|March 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Pediatric Blood & Cancer|March 21, 2014
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)Naima A Al-Mulla, Prem Chandra, Mohammed Khattab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaDeepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
Pediatric Blood & Cancer|January 19, 2017
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statementJamie E Flerlage, Kara M Kelly, Auke Beishuizen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|November 19, 2015
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd editionHellen Gelband, Rengaswamy Sankaranarayanan, Cindy L Gauvreau, et al.
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
British Journal of Haematology|April 3, 2015
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group studyTerzah M Horton, Richard A Drachtman, Lu Chen, et al.
Cancers|January 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European RegistryBertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Cancers|March 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Pediatric Blood & Cancer|March 21, 2014
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)Naima A Al-Mulla, Prem Chandra, Mohammed Khattab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaDeepa Bhojwani, Noah D Sabin, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
Pediatric Blood & Cancer|January 19, 2017
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statementJamie E Flerlage, Kara M Kelly, Auke Beishuizen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.
Pageof 20